ONOE K. | Department of Molecular Neuroscience, Institute of Medical Science, Tokai University School of Medic
スポンサーリンク
概要
- 同名の論文著者
- Department of Molecular Neuroscience, Institute of Medical Science, Tokai University School of Medicの論文著者
関連著者
-
ONOE K.
Department of Molecular Neuroscience, Institute of Medical Science, Tokai University School of Medic
-
SHINOHARA Y.
Department of Neurology, Tokai University School of Medicine
-
Tsuda M.
Department of Applied Physics, Osaka University
-
SAKAI H.
Department of Chemistry, Graduate School of Science, Kyoto University
-
TAKAGI S.
Department of Anatomy, Shimane Medical University, Department of DNA Biology, School of Medicine, To
-
Onoe K.
Sla Research Inc.
-
OSUGA H.
NeuroGenes Project,International Cooperative Research Project, Japan Science and Technology Corporat
-
OTOMO A.
Department of Molecular Neuroscience, Institute of Medical Science, Tokai University School of Medic
-
YOSHII F.
Department of Neurology, Tokai University School of Medicine
-
IKEDA J.
NeuroGenes Project,International Cooperative Research Project, Japan Science and Technology Corporat
-
OSUGA H.
Department of Neurology, Institute of Medical Science, Tokai University School of Medicine
-
IKEDA J.-E.
SLA Research Inc.
-
Osuga H.
Department Of Neurology Institute Of Medical Science Tokai University School Of Medicine
-
Onoe K.
Departments Of Neurology Tokai University School Of Medicine
-
TACHIKAWA H.
Departments of Neurology, Tokai University School of Medicine
-
TAKAHASHI W.
HIMEDIC Imaging Center at Lake Yamanaka
-
SEKIYAMA S.
Departments of Neurology, Tokai University School of Medicine
-
Sekiyama S.
Department Of Neurology Tokai University Oiso Hospital
-
Sekiyama S.
Departments Of Neurology Tokai University School Of Medicine
-
Yoshii F.
Department Of Neurology Institute Of Medical Science Tokai University School Of Medicine
著作論文
- THE UPREGULATION OF NEURONAL APOPTOSIS INHIBITORY PROTEIN IN RAT PERMANENT FOCAL ISCHEMIA MODEL
- ASSOCIATION OF VARIANT α-1-ANTICHYMOTRYPSIN GENE (ACT ISEHARA-1) WITH INCREASED RISK OF CEREBROVASCULAR DISEASE